managment acting, page-2

In the current market, money can be made so easily (e.g. ADY) so this leads to investor impatience with drug companies, it's an industry where a product takes years to come to market. As a result the whole sector is out of favour, simply because of the easy money to be made elsewhere. Things will change when they start talking about being able to sell something. We've been holding this since they were BNA and could sell today at 100% profit but that's not why we bought them...